Gallagher Kathleen P. bought RNA
February 3, 2025 · Form 4 insider transaction
Gallagher Kathleen P. bought 5,875 shares of Atrium Therapeutics, Inc. at $16.65 per share, a transaction worth $97.8K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
5,875
Price
$16.65
Total value
$97.8K
InsiderGallagher Kathleen P.
RoleOfficer, Director
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateFebruary 3, 2025
Filing dateFebruary 5, 2025
Shares owned after56,429
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This option exercise and sale was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on June 12, 2024.